RVP vs BDX vs BAX Stock Comparison

Retractable Technologies, Becton Dickinson and Baxter International Prices as of Nov 2, 2026 Peers: Industry group
1 more company in this comparison (UEEC) Create a free account to keep reading and compare up to 10 companies.
BDX Becton Dickinson & Co
$198.54 +12.3% 1M +11.1% 1Y
Market cap
$54.08B
P/E
58.0x
Revenue (TTM)
$23.25B
Div. yield
2.12%
Medical Supplies Healthcare
8 wins
BAX Baxter International Inc
$24.22 +3.1% 1M +31.1% 1Y
Market cap
$12.53B
P/E
–
Revenue (TTM)
$11.61B
Div. yield
0.17%
Medical Supplies Healthcare
2 wins

Head to Head

11 decided of 12

Becton Dickinson leads on 8 of the 12 questions below (Becton Dickinson 8, Baxter International 2, Retractable Technologies 1). Which ones matter depends on what you are buying for; a cheap multiple and slow growth often come together.

QuestionRVPBDXBAXLeader
Larger companyMarket capitalisation $17.06M $54.08B $12.53B BDX
Cheaper on earningsLower P/E, profitable companies only -4.7x 58.0x -17.3x –
Cheaper on forward earningsLower price / next fiscal year consensus EPS — 15.3x 12.2x BAX
Faster revenue growthRevenue growth, trailing twelve months -11.2% +17.4% +5.3% BDX
More profitableNet margin, trailing twelve months -10.6% 4.0% -6.2% BDX
Better return on capitalReturn on invested capital -31.4% 5.3% -1.4% BDX
Less leveragedLower net debt / EBITDA 2.6x 3.2x 9.0x RVP
Higher dividend yieldTrailing dividend yield — 2.12% 0.17% BDX
Better 1-year returnPrice return, last 12 months -35.1% +11.1% +31.1% BAX
Better 5-year returnAnnualised price return, 5 years -42.9%/yr -4.3%/yr -21.3%/yr BDX
Less volatileAnnualised volatility, 1 year 40.2% 31.9% 42.5% BDX
Higher overall scoreMean of the five percentile scores vs peers 53/100 67/100 44/100 BDX

Percentile Scorecard

RVPBDXBAX

Each axis is the mean percentile of its metrics against the company's industry group. 100 is the best in the group, 50 the middle.

Scores by Axis

AxisRVPBDXBAX
Valuation 73 #63 of 227 89 #25 of 227 88 #29 of 227
Growth 34 #145 of 220 48 #115 of 220 14 #189 of 220
Profitability 38 #130 of 209 77 #49 of 209 65 #73 of 209
Financial Health 65 #84 of 240 26 #177 of 240 18 #198 of 240
Shareholder Returns – 95 #8 of 138 34 #91 of 138
Overall 53 67 44
  • RVP ranked among 247 companies in Medical Devices and Diagnostics
  • BDX ranked among 247 companies in Medical Devices and Diagnostics
  • BAX ranked among 247 companies in Medical Devices and Diagnostics

Price Performance

Price return, split-adjusted, before dividends. Click a name to hide or show it.

Returns

PeriodRVPBDXBAXSPY
1 month -18.6%+12.3%+3.1% -2.3%
3 months -14.9%+16.7%-13.8% -0.7%
6 months -12.3%+35.7%+45.7% +4.8%
Year to date -26.2%+2.3%+26.7% +10.3%
1 year -35.1%+11.1%+31.1% +10.3%
3 years -48.6%-23.3%-28.7% +73.0%
3 years, per year -19.9%-8.5%-10.7% +20.1%
5 years -93.9%-19.6%-69.7% +61.9%
5 years, per year -42.9%-4.3%-21.3% +10.1%
10 years -78.2%+19.0%-48.2% +258.6%
10 years, per year -14.1%+1.8%-6.4% +13.6%

Risk

MeasureRVPBDXBAXSPY
Volatility, 1Y 40.2%31.9%42.5% 12.8%
Downside volatility, 1Y 44.8%33.3%44.1% 12.8%
Beta vs S&P 500, 1Y 0.150.321.07 1.00
Return / volatility, 1Y -0.870.350.73 0.80
Max drawdown, 5Y -93.9%-50.4%-82.3% -25.4%
From 52-week high -35.3%-5.5%-14.6% -3.5%
52-week high $0.88$210.02$28.35 $779.14
52-week low $0.57$140.71$15.80 $631.97

Valuation History

Weekly multiples on trailing twelve-month fundamentals. Negative or extreme readings (a loss year, a collapsed denominator) are left out so the chart stays readable.

MultipleRVPBDXBAX
P/E now vs peer median -4.7xmedian 28.4x 58.0xmedian 28.4x -17.3xmedian 28.4x
P/S now vs peer median 0.5xmedian 3.0x 2.3xmedian 3.0x 1.1xmedian 3.0x
EV/EBITDA now vs peer median 1.5xmedian 18.0x 14.1xmedian 18.0x 26.1xmedian 18.0x
P/FCF now vs peer median -3.3xmedian 25.0x 16.9xmedian 25.0x 10.8xmedian 25.0x
P/B now vs peer median 0.2xmedian 2.3x 2.2xmedian 2.3x 1.9xmedian 2.3x
PEG now vs peer median 0.22median 0.93 -3.97median 0.93 0.55median 0.93

Financial History

Reported figures by fiscal period, placed on the calendar year (or quarter) each period ended in, so companies with different fiscal years line up.

Trailing twelve monthsRVPBDXBAX
Revenue $33.90M $23.25B $11.61B
Gross profit -$491.51K $10.91B $3.49B
Operating income -$22.68M $2.48B -$221.00M
Net income -$3.37M $941.00M -$723.00M
Free cash flow -$5.11M $3.20B $1.16B
R&D $682.03K $1.37B $519.00M
EPS (diluted) $-0.12 $3.42 $-1.39
Cash & equivalents $2.64M $708.00M $1.98B
Total debt $715.92K $16.81B $8.60B
Shares (diluted) 29.94M 275.16M 520.00M
Enterprise value -$129.34M $51.23B $4.38B

All Metrics

58 metrics · best in bold

Bold marks the best reading: the lowest positive value for multiples, leverage and payout, the highest for everything else. The bar under each value is its percentile against that company's own peers. Hover a value for its rank and the peer median.

Valuation

12 metrics
MetricRVPBDXBAX
P/E -4.7x 58.0x -17.3x
P/FCF -3.3x 16.9x 10.8x
P/Operating cash flow -3.4x 13.7x 7.5x
P/S 0.5x 2.3x 1.1x
P/B 0.2x 2.2x 1.9x
P/Tangible book 0.2x 2.3x 4.9x
EV/EBITDA 1.5x 14.1x 26.1x
EV/EBIT 1.0x 28.3x -86.7x
EV/Revenue -0.7x 3.0x 1.6x
EV/FCF 4.3x 21.9x 16.5x
EV/Operating cash flow 4.5x 17.7x 11.5x
PEG (3Y EPS CAGR) 0.22 -3.97 0.55

Growth

14 metrics
MetricRVPBDXBAX
Revenue growth (1Y) -11.2% 17.4% 5.3%
Revenue CAGR (3Y) -14.7% 6.9% 0.7%
Gross profit growth (1Y) 81.2% 23.7% -7.1%
Gross profit CAGR (3Y) -26.8% 8.5% -7.7%
Operating income growth (1Y) -2.3% 13.0% -136.3%
Operating income CAGR (3Y) -11.7% 3.3% 4.2%
Net income growth (1Y) 61.4% -40.6% -112.0%
Net income CAGR (3Y) -23.9% -17.3% -31.6%
EPS growth (1Y) 59.8% -38.0% -109.6%
EPS CAGR (3Y) -21.9% -14.6% -31.5%
Operating cash flow growth (1Y) 58.8% 43.5% 97.4%
Operating cash flow CAGR (3Y) -16.8% 14.5% 0.6%
Free cash flow growth (1Y) 62.3% 54.2% 243.5%
Free cash flow CAGR (3Y) 20.0% 22.5% -5.0%

Profitability

14 metrics
MetricRVPBDXBAX
Gross margin -1.4% 46.9% 30.1%
EBITDA margin -43.9% 21.4% 6.3%
Operating margin -66.9% 10.7% -1.9%
Pretax margin -9.9% 8.4% -1.6%
Net margin -10.6% 4.0% -6.2%
FCF margin -15.1% 13.8% 10.0%
Operating cash flow margin -14.6% 17.0% 14.3%
Return on equity -4.7% 3.9% -11.4%
Return on assets -2.4% 1.9% -3.7%
Return on invested capital -31.4% 5.3% -1.4%
Return on capital employed -18.0% 6.0% -1.4%
Asset turnover 0.2x 0.5x 0.6x
Cash conversion (OCF / net income) 1.5x 4.2x -2.3x
Stock comp / revenue – 1.2% 0.9%

Financial Health

11 metrics
MetricRVPBDXBAX
Debt / assets 0.5% 33.1% 44.3%
Debt / equity 0.0x 0.7x 1.3x
Net debt / EBITDA 2.6x 3.2x 9.0x
Debt / FCF -0.1x 5.2x 7.4x
Liabilities / assets 48.6% 51.9% 66.5%
Equity / assets 51.4% 48.1% 33.5%
Interest coverage -278.8x 4.2x –
Current ratio 4.9x 0.9x 1.8x
Quick ratio 3.7x 0.3x 1.0x
Cash ratio 3.0x 0.1x 0.5x
Altman Z-score 0.43 2.31 2.35

Shareholder Returns

7 metrics
MetricRVPBDXBAX
Dividend yield – 2.1% 0.2%
Net buyback yield – 4.6% -0.2%
Shareholder yield – 6.7% 0.0%
Payout ratio (earnings) – – -14.1%
Payout ratio (FCF) – – 8.8%
Dividend growth (1Y) – – -75.0%
Dividend CAGR (3Y) – – -44.1%

Analyst Estimates

Solid lines are reported fiscal-year results; dashed lines are the consensus for the years ahead. Hover a year for the analysts' high and low, and how each result compared with its estimate.

ConsensusRVPBDXBAX
Forward P/E – 15.3xFY2026 12.2xFY2026
EPS, next fiscal year – $12.99FY2026 $1.98FY2026
EPS growth, next FY – +14.8%FY2026 -10.4%FY2026
EPS growth, the year after – -2.9% -3.5%
Revenue, next fiscal year – $18.11BFY2026 $11.05BFY2026
Revenue growth, next FY – -17.1%FY2026 -1.7%FY2026
Revenue growth, the year after – +11.6% +11.7%

Institutional Ownership

13F filings, quarter ended Jun 30, 2026
HoldersRVPBDXBAX
Held by institutions 8.8% 96.1% 100.0%
Institutions holding 32 1,444 692
Change in shares held, QoQ +5.9% +0.6% +5.2%
Institutions buying 10 688 359
Institutions selling 4 545 194
Buyers to sellers 2.50 1.26 1.85

Return Correlation

Daily returns, last 12 months

1.00 means two stocks move in lockstep, 0 that they move independently. Pairs below about 0.5 diversify each other.

RVPBDXBAX
RVP 1.00 0.01 0.03
BDX 0.01 1.00 0.39
BAX 0.03 0.39 1.00

Add a Peer

Largest companies in the same industry

Related Comparisons

Frequently Asked Questions

Which is bigger, RVP, BDX and BAX?

Becton Dickinson (BDX) is the largest by market capitalisation: Retractable Technologies (RVP) $17.06M, Becton Dickinson (BDX) $54.08B, Baxter International (BAX) $12.53B.

Which company is growing faster?

Becton Dickinson (BDX) grew revenue fastest over the trailing twelve months: Retractable Technologies (RVP) -11.2%, Becton Dickinson (BDX) +17.4%, Baxter International (BAX) +5.3%.

Which company is more profitable?

Becton Dickinson (BDX) has the highest net margin (Retractable Technologies (RVP) -10.6%, Becton Dickinson (BDX) 4.0%, Baxter International (BAX) -6.2%). On return on invested capital, Becton Dickinson (BDX) leads (Retractable Technologies (RVP) -31.4%, Becton Dickinson (BDX) 5.3%, Baxter International (BAX) -1.4%).

Which stock has performed better?

Over the past year Baxter International (BAX) returned the most: Retractable Technologies (RVP) -35.1%, Becton Dickinson (BDX) +11.1%, Baxter International (BAX) +31.1%. Over five years, Becton Dickinson (BDX) compounded fastest (Retractable Technologies (RVP) -42.9%/yr, Becton Dickinson (BDX) -4.3%/yr, Baxter International (BAX) -21.3%/yr). Returns are price only, before dividends.

Which pays a higher dividend?

Becton Dickinson (BDX) has the highest dividend yield: Becton Dickinson (BDX) 2.12%, Baxter International (BAX) 0.17%. Retractable Technologies (RVP) pays no regular dividend.

Which stock is riskier?

By one-year price volatility, Becton Dickinson (BDX) has been the steadiest (Retractable Technologies (RVP) 40.2%, Becton Dickinson (BDX) 31.9%, Baxter International (BAX) 42.5%). Volatility measures how widely the price swings, not the risk of the business.

Which is the better stock, RVP, BDX and BAX?

There is no single answer; it depends on what you are buying for. On the 12 head-to-head measures on this page, Becton Dickinson (BDX) leads on 8. Business Quant does not give investment advice; use the comparison as a starting point for your own research.

Data from SEC filings, exchange prices and consensus estimates, via Business Quant. Percentile scores compare each company with its own peer group, so two companies' scores are each relative to different peers unless you rank against the whole market. Price returns exclude dividends. Nothing on this page is investment advice.